Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Clinical trial NCT01910389 · TERMINATED
Trial details
- NCT number
- NCT01910389
- Sponsor
- Carelon Research
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.